TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

DESFLURANE

DESFLURANE
Respiratory Approved 2018-02-26
1
Indication
--
Phase 3 Trials
8
Years on Market

Details

Status
Prescription
First Approved
2018-02-26
Routes
INHALATION
Dosage Forms
LIQUID

Companies

Active Ingredient: DESFLURANE

DESFLURANE Approval History

Loading approval history...

What DESFLURANE Treats

1 indications

DESFLURANE is approved for 1 conditions since its original approval in 2018. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Anesthesia
Source: FDA Label
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

DESFLURANE FDA Label Details

Pro

Indications & Usage

Desflurane, USP, Liquid for Inhalation, a general anesthetic, is an inhalation agent indicated: for induction and/or maintenance of anesthesia in adults for maintenance of anesthesia in pediatric patients following induction with agents other than Desflurane, USP, Liquid for Inhalation and intubation. 1.1 Induction of Anesthesia Desflurane, USP, Liquid for Inhalation is indicated as an inhalation agent for induction of anesthesia for inpatient and outpatient surgery in adults. Desflurane, USP, Liquid for Inhalation is contraindicated as an inhalation agent for the induction of anesthesia in pe...

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.